SARS-COV-2 VACCINE(VERO CELL), INACTIVATED
Cooperated with CDC, the virus we used strain with high-titer and immunogenicity was obtained. The completed acute toxicity study and animal allergy study showcased high immuno-protection efficacy. We completed more than 20 batches of virus culture and more than 10 batches of purification and formulation, with analytical test methodology and specifications established. Toxicity studies results demonstrated excellent safety feature.